CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes

por Schmidt, R, Baumann, F, Knüpfer, H, Brauckhoff, M, Horn, L-C, Schönfelder, M, Köhler, U, Preiss, R
Publicado 2004

Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients

por Bader-Meunier, B, Hachulla, P, Kuemmerle-Deschner, J, Gattorno, M, Patel, N, Preiss, R, Lheritier, K, Imagawa, T, Nishikomori, R, Takada, H, Heike, T, Hara, T, Yokota, S
Publicado 2011

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a...

por Ruperto, N, Brunner, H, Horneff, G, Quartier, P, Constantin, T, Berkun, Y, Erguven, M, Kallinich, T, Brik, R, Wulffraat, NM, Ferrandiz, MA, Rutkowska-Sak, L, Ozdogan, H, McCann, L, Lheritier, K, Preiss, R, Tseng, L, Martini, A, Lovell, DJ
Publicado 2011